Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Diabetes

  Free Subscription


Articles published in J Am Soc Nephrol

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    January 2012
  1. GOHDA T , Niewczas MA, Ficociello LH, Walker WH, et al
    Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes.
    J Am Soc Nephrol. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. NIEWCZAS MA , Gohda T, Skupien J, Smiles AM, et al
    Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes.
    J Am Soc Nephrol. 2012.
    PubMed     Text format     Related articles    Abstract available



  3. BADAL SS , Danesh FR
    Managing Microvascular Complications of Diabetes with MicroRNAs.
    J Am Soc Nephrol. 2012.
    PubMed     Text format     Related articles   



  4. PUTTA S , Lanting L, Sun G, Lawson G, et al
    Inhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic Nephropathy.
    J Am Soc Nephrol. 2012.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  5. CONWAY BR , Rennie J, Bailey MA, Dunbar DR, et al
    Hyperglycemia and Renin-Dependent Hypertension Synergize to Model Diabetic Nephropathy.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



  6. CHEN JL , Francis J
    Pyridoxamine, Advanced Glycation Inhibition, and Diabetic Nephropathy.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles   



    November 2011
  7. FRIEDMAN DJ , Kozlitina J, Genovese G, Jog P, et al
    Population-based risk assessment of APOL1 on renal disease.
    J Am Soc Nephrol. 2011;22:2098-105.
    PubMed     Text format     Related articles    Abstract available



  8. MADHAVAN SM , O'Toole JF, Konieczkowski M, Ganesan S, et al
    APOL1 localization in normal kidney and nondiabetic kidney disease.
    J Am Soc Nephrol. 2011;22:2119-28.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  9. LEWIS EJ , Greene T, Spitalewiz S, Blumenthal S, et al
    Pyridorin in Type 2 Diabetic Nephropathy.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



  10. PACKHAM DK , Wolfe R, Reutens AT, Berl T, et al
    Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



  11. REDDY MA , Natarajan R
    Epigenetics in Diabetic Kidney Disease.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



  12. YI X , Xu L, Hiller S, Kim HS, et al
    Reduced Expression of Lipoic Acid Synthase Accelerates Diabetic Nephropathy.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



  13. LIN M , Yiu WH, Wu HJ, Chan LY, et al
    Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  14. INOUE T , Kozawa E, Okada H, Inukai K, et al
    Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging.
    J Am Soc Nephrol. 2011;22:1429-34.
    PubMed     Text format     Related articles    Abstract available



  15. GUERRA G , Ciancio G, Gaynor JJ, Zarak A, et al
    Randomized Trial of Immunosuppressive Regimens in Renal Transplantation.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  16. CHENG H , Fan X, Moeckel GW, Harris RC, et al
    Podocyte COX-2 Exacerbates Diabetic Nephropathy by Increasing Podocyte (Pro)renin Receptor Expression.
    J Am Soc Nephrol. 2011;22:1240-51.
    PubMed     Text format     Related articles    Abstract available



  17. WANNER C , Krane V
    Sunrise of statins after AURORA and 4D?
    J Am Soc Nephrol. 2011;22:1184-6.
    PubMed     Text format     Related articles   



    June 2011
  18. LEVIN A , Beaulieu MC
    Trials and tribulations of new agents, novel biomarkers, and retarding renal progression.
    J Am Soc Nephrol. 2011;22:992-3.
    PubMed     Text format     Related articles   



    May 2011
  19. HOLDAAS H , Holme I, Schmieder RE, Jardine AG, et al
    Rosuvastatin in Diabetic Hemodialysis Patients.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  20. SHARMA K , Ix JH, Mathew AV, Cho M, et al
    Pirfenidone for Diabetic Nephropathy.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles   



  21. LOEFFLER I , Hopfer U, Koczan D, Wolf G, et al
    Type VIII collagen modulates TGF-beta1-induced proliferation of mesangial cells.
    J Am Soc Nephrol. 2011;22:649-63.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  22. RITZ E , Wenzel RR
    Endothelin Antagonist as Add-on Treatment for Proteinuria in Diabetic Nephropathy: Is There Light at the End of the Tunnel?
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles   



  23. FENSKE W , Wanner C, Allolio B, Drechsler C, et al
    Copeptin Levels Associate with Cardiovascular Events in Patients with ESRD and Type 2 Diabetes Mellitus.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



  24. KOHAN DE , Pritchett Y, Molitch M, Wen S, et al
    Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  25. NELSON RG
    Is Treatment of Nephropathy in Type 1 Diabetes Efficacious but Ineffective?
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles   



  26. ROSOLOWSKY ET , Skupien J, Smiles AM, Niewczas M, et al
    Risk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



  27. FORSBLOM C , Harjutsalo V, Thorn LM, Waden J, et al
    Competing-Risk Analysis of ESRD and Death among Patients with Type 1 Diabetes and Macroalbuminuria.
    J Am Soc Nephrol. 2011.
    PubMed     Text format     Related articles    Abstract available



  28. VELAGAPUDI C , Bhandari BS, Abboud-Werner S, Simone S, et al
    The Tuberin/mTOR Pathway Promotes Apoptosis of Tubular Epithelial Cells in Diabetes.
    J Am Soc Nephrol. 2011;22:262-73.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  29. LY JP , Onay T, Sison K, Sivaskandarajah G, et al
    The Sweet Pee model for Sglt2 mutation.
    J Am Soc Nephrol. 2011;22:113-23.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  30. JOHNSON RJ , Sanchez-Lozada LG, Nakagawa T
    The effect of fructose on renal biology and disease.
    J Am Soc Nephrol. 2010;21:2036-9.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: